Streetbeat News

Stock Prices

IMCR

JP Morgan analyst Jessica Fye has reinstated Immunocore Holdings (NASDAQ:IMCR) with an Overweight rating and set a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 1:04 pm

HRYU

Hanryu Holdings (NASDAQ:HRYU) reported a decline in Q3 earnings per share from $(0.03) to $(0.06) year-over-year, and a 4.66% decrease in sales from $748.66K to $713.76K.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 1:04 pm

TTGT

TechTarget (NASDAQ:TTGT) has received 4 analyst ratings in the last quarter, with an average price target of $33.5, representing an implied upside from the current price of $29.26. The consensus among the analysts is more bullish, with 1 bullish, 2 somewhat bullish, and 1 indifferent rating. The average price target has increased by 4.69% over the past month.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 1:01 pm

SKWD

Over the past 3 months, 4 Wall Street analysts have provided ratings for Skyward Specialty (NASDAQ:SKWD), with 2 giving a bullish and 2 a somewhat bullish outlook. The average price target is $35.25, representing an implied upside from the current price of $30.3. This target has increased by 13.71% over the past month. Analysts typically review stocks quarterly, using various methods to predict stock performance.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 1:00 pm

CHPT

ChargePoint Holdings (NYSE:CHPT) has received 16 analyst ratings in the last quarter, with an average price target of $10.02, which is significantly higher than its current price of $2.02. The ratings are predominantly bullish or somewhat bullish, with no bearish or somewhat bearish ratings. The current average price target has decreased by 26.49% from the previous average of $13.63.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 1:00 pm

MDT

The FDA has approved Medtronic plc's Symplicity Spyral renal denervation system for treating hypertension. Despite initial doubts from the FDA Circulatory System Devices Panel, which was divided on the benefit/risk profile, the device will now be commercialized by Medtronic. The Symplicity procedure is minimally invasive and is already approved in over 70 countries. Medtronic's stock (MDT) rose 1.12% in premarket trading following the announcement.

Portfolio Pulse from Vandana Singh

November 20, 2023 | 12:57 pm

NIO

Nio Inc (NYSE:NIO) has reached a milestone by activating its 2,100th power swap station, nearing its target of 2,300 stations by year-end. This development emphasizes Nio's commitment to battery-swapping services, which is a different approach compared to other EV manufacturers like Tesla, Volkswagen, and General Motors that focus on battery charging. Nio's strategy could enhance the EV charging experience for its users.

Portfolio Pulse from Anan Ashraf

November 20, 2023 | 12:55 pm

SCNI

Scinai Immunotherapeutics has regained compliance with Nasdaq's minimum stockholders' equity listing rules, avoiding potential delisting issues.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:52 pm

NIU

Niu Technologies (NASDAQ:NIU) reported a significant decline in Q3 FY23 with revenues down 19.6% to $127.06 million and a shift from adjusted net income to a net loss. E-scooter sales dropped by 17.1% Y/Y, with a notable decrease in both China and international markets. The company is facing a challenging quarter with a lower gross margin and an increased operating loss. Despite the downturn, Niu is focusing on the mass-premium market and expects Q4 revenues to potentially decrease by up to 20% Y/Y. NIU shares fell by 4.66% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

November 20, 2023 | 12:50 pm

COF

HD

SNAP

TGT

Insiders at Snap Inc., The Home Depot, Target Corporation, and Capital One Financial have recently sold shares of their companies. Snap's CFO sold shares amid a small number of layoffs and company reorganization. Home Depot's SVP-Finance, CAO & Controller sold shares after reporting strong Q3 results. Target's Executive Officer sold shares also following better-than-expected Q3 results. Capital One Financial's Director sold shares after the company reported positive Q3 financials. Insider sales can indicate various sentiments and should not be the sole basis for investment decisions.

Portfolio Pulse from Lisa Levin

November 20, 2023 | 12:48 pm